参考文献
[1]McGuire W L.Breast cancer prognostic factors：evaluationguidelines.‘，Natl Cancer Inst，1991，83：154-155.
[2]Ahman D G，Lyman G H.Methodological challenges in the evaluation of prognostic factors in breast cance r.B M Cancer Res Treat，1998，52：289-303.
[3]Hammond M E，Fitzgibbons P L，Compton C C，et al.Col-lege of American Pathologists Conference XXXV：solid tumor prognostic factors-which，how and SO what?Sum-mary Document and recommendations for implementatiorL Cancer Committee and Conference Participants.Arch Pathol Lab Med，2000，124：958-965.
[4]Giuseppe Canavese，Alessandra Catturich，Carlo Vecchio，et al.Prognostic role of lymph-node level involvement inpatients undergoing axillary dissection for breast canceL EurJ SurgOncol，1998，Apr；24(2)：104-109.
[5]Masakuni Noguchi.Current Surgical Oneology in Breast Cancer.Kanazawa Japan：Maeda Shoten Co.Ltd，2001，199-247.
[6]Clark G M.Interpreting and integrating risk factors for pa-tients with primary breast cancer.J Natl Ca”cPr Inst Monogr，2001，17-21.
[7]Hayes D F，Trock B，Harris A L.Assessing the clinical im-pact of prognostic factors：when is“statistically signifi-cant”clinically useful?Breast Cancer Res Treat，1998，52：305-319.(https://www.daowen.com)
[8]Wenger C R，Beardslee S，Owens M A，et al.DNA ploidy，S-phase，and steroid receptors in more than 127 000 breast cancer patients.Beeast Canter Res Treat，1993，28：9-20.
[9]Crowe JP Jr，Gordon N H，Hubay C A，et al.Estrogen re-ceptor determination and long lerm survival of patients with carcinoma of the breast.Sure Gynecol ObstPt，1991，173：273-278.
[10]Mendelsohn J，BaselgaJ.TheEGFreceptorfamily as targets for cancer therapy.Oncogene，2000，19：6550-6565.
[11]Stephens R W，Brunner N，Janiche F，et al.The urokinase plasminogen activator system as a target for prognostic studies in breast cancer.Breast cancer Res n℃nt，1998，52：99-111.
[12]Look M P，van Putten W L，Duffy M J，et al.Pooled analy-sis of prognostic impact ofurokinase-type plasminogen activator and its inhibitor PALl in 8377 breast cancer pa-tients.J NⅡtl Cancer Inst，2002，94：116-128.
[13]Elledge R M，Allred D C.Prognostic and predictive value of p53 and p21 in breast cancer.Breast cancer Res Treat，1998，52：79-98.
[14]Krajewski S，Krajewska M，Turner B C，et al.Prognosticsignificance of apoptosis regulators in breast cancer.En-docrRelat Cancer，1999，6：29-40.